NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $524,363 | -9.1% | 11,850 | 0.0% | 0.05% | +12.8% |
| Q2 2023 | $576,621 | -12.4% | 11,850 | 0.0% | 0.05% | -29.9% |
| Q1 2023 | $657,912 | +38.2% | 11,850 | 0.0% | 0.07% | +59.5% |
| Q4 2022 | $476,015 | -8.3% | 11,850 | 0.0% | 0.04% | -16.0% |
| Q3 2022 | $519,000 | +12.8% | 11,850 | 0.0% | 0.05% | +16.3% |
| Q2 2022 | $460,000 | -4.6% | 11,850 | 0.0% | 0.04% | +16.2% |
| Q1 2022 | $482,000 | -34.2% | 11,850 | +51.0% | 0.04% | -36.2% |
| Q4 2021 | $733,000 | -17.3% | 7,850 | -1.3% | 0.06% | -27.5% |
| Q3 2021 | $886,000 | -1.9% | 7,950 | 0.0% | 0.08% | -4.8% |
| Q2 2021 | $903,000 | +11.9% | 7,950 | 0.0% | 0.08% | +5.0% |
| Q1 2021 | $807,000 | -27.6% | 7,950 | -29.0% | 0.08% | -37.0% |
| Q4 2020 | $1,115,000 | +2.2% | 11,200 | -25.8% | 0.13% | -29.4% |
| Q3 2020 | $1,091,000 | +44.9% | 15,100 | 0.0% | 0.18% | +71.4% |
| Q2 2020 | $753,000 | – | 15,100 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |